158 related articles for article (PubMed ID: 27507614)
41. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C
Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511
[TBL] [Abstract][Full Text] [Related]
42. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
[TBL] [Abstract][Full Text] [Related]
43. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma.
Yuan RH; Jeng YM; Pan HW; Hu FC; Lai PL; Lee PH; Hsu HC
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5368-76. PubMed ID: 17875765
[TBL] [Abstract][Full Text] [Related]
45. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.
Ren F; Wu H; Lei Y; Zhang H; Liu R; Zhao Y; Chen X; Zeng D; Tong A; Chen L; Wei Y; Huang C
Mol Cancer; 2010 Apr; 9():81. PubMed ID: 20403181
[TBL] [Abstract][Full Text] [Related]
46. BORIS, brother of the regulator of imprinted sites, is aberrantly expressed in hepatocellular carcinoma.
Chen K; Huang W; Huang B; Wei Y; Li B; Ge Y; Qin Y
Genet Test Mol Biomarkers; 2013 Feb; 17(2):160-5. PubMed ID: 23237599
[TBL] [Abstract][Full Text] [Related]
47. The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma.
Jiang C; Hu F; Tai Y; Du J; Mao B; Yuan Z; Wang Y; Wei L
J Cancer Res Clin Oncol; 2012 Apr; 138(4):637-46. PubMed ID: 22228034
[TBL] [Abstract][Full Text] [Related]
48. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
49. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.
Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B
BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
[TBL] [Abstract][Full Text] [Related]
51. [Expression of genes related to Sonic Hedgehog signaling in human hepatocellular carcinomas].
Che L; Ren J; Yuan YH; Jia J; Di LJ; Song GH; Yu J; Wang XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):616-23. PubMed ID: 19088834
[TBL] [Abstract][Full Text] [Related]
52. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma.
Wang Y; Chen CL; Pan QZ; Wu YY; Zhao JJ; Jiang SS; Chao J; Zhang XF; Zhang HX; Zhou ZQ; Tang Y; Huang XQ; Zhang JH; Xia JC
Oncotarget; 2016 Feb; 7(5):6323-34. PubMed ID: 26575170
[TBL] [Abstract][Full Text] [Related]
53. Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II.
Gong L; Cui Z; Chen P; Han H; Peng J; Leng X
Med Oncol; 2012 Jun; 29(2):909-14. PubMed ID: 21279699
[TBL] [Abstract][Full Text] [Related]
54. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Aigelsreiter A; Ress AL; Bettermann K; Schauer S; Koller K; Eisner F; Kiesslich T; Stojakovic T; Samonigg H; Kornprat P; Lackner C; Haybaeck J; Pichler M
Br J Cancer; 2013 May; 108(9):1830-7. PubMed ID: 23591196
[TBL] [Abstract][Full Text] [Related]
55. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.
Endo K; Terada T
J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma.
Guo X; Xiong L; Zou L; Zhao J
Pathol Oncol Res; 2012 Jul; 18(3):635-40. PubMed ID: 22350792
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.
Liu L; Zhang CZ; Cai M; Fu J; Chen GG; Yun J
PLoS One; 2012; 7(7):e41293. PubMed ID: 22829937
[TBL] [Abstract][Full Text] [Related]
58. LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis.
Huang X; Ji G; Wu Y; Wan B; Yu L
J Cancer Res Clin Oncol; 2008 Jun; 134(6):705-14. PubMed ID: 18084776
[TBL] [Abstract][Full Text] [Related]
59. Tas13D inhibits growth of SMMC-7721 cell via suppression VEGF and EGF expression.
He HZ; Wang N; Zhang J; Zheng L; Zhang YM
Asian Pac J Cancer Prev; 2012; 13(5):2009-14. PubMed ID: 22901163
[TBL] [Abstract][Full Text] [Related]
60. Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA.
Yu D; Dong Z; Yao M; Wu W; Yan M; Yan X; Qiu L; Chen J; Sai W; Yao D
Tumour Biol; 2013 Apr; 34(2):661-8. PubMed ID: 23192642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
